GMO U.S. Quality ETF $QLTY Stock Position Decreased by Acumen Wealth Advisors LLC

Acumen Wealth Advisors LLC reduced its stake in GMO U.S. Quality ETF (NYSEARCA:QLTYFree Report) by 96.0% in the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 2,180 shares of the company’s stock after selling 51,824 shares during the period. Acumen Wealth Advisors LLC’s holdings in GMO U.S. Quality ETF were worth $79,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also made changes to their positions in the stock. Aspen Investment Management Inc grew its position in shares of GMO U.S. Quality ETF by 4.6% during the first quarter. Aspen Investment Management Inc now owns 27,800 shares of the company’s stock worth $1,006,000 after acquiring an additional 1,210 shares during the last quarter. Sprinkle Financial Consultants LLC lifted its holdings in GMO U.S. Quality ETF by 10.5% in the 1st quarter. Sprinkle Financial Consultants LLC now owns 87,268 shares of the company’s stock valued at $3,157,000 after acquiring an additional 8,264 shares during the last quarter. Allegheny Financial Group raised its holdings in shares of GMO U.S. Quality ETF by 64.0% in the 1st quarter. Allegheny Financial Group now owns 400,548 shares of the company’s stock worth $14,492,000 after purchasing an additional 156,371 shares in the last quarter. Stonehearth Capital Management LLC lifted its stake in GMO U.S. Quality ETF by 4.8% during the first quarter. Stonehearth Capital Management LLC now owns 440,926 shares of the company’s stock valued at $15,953,000 after purchasing an additional 20,133 shares during the last quarter. Finally, CENTRAL TRUST Co boosted its holdings in GMO U.S. Quality ETF by 35.7% during the first quarter. CENTRAL TRUST Co now owns 820,980 shares of the company’s stock worth $29,703,000 after buying an additional 215,930 shares in the last quarter. 85.37% of the stock is currently owned by institutional investors and hedge funds.

GMO U.S. Quality ETF Price Performance

Shares of QLTY opened at $41.32 on Wednesday. The company has a 50-day moving average of $41.18 and a two-hundred day moving average of $39.48. The stock has a market cap of $4.76 billion, a price-to-earnings ratio of 57.39 and a beta of 0.97. GMO U.S. Quality ETF has a one year low of $33.56 and a one year high of $42.06.

About GMO U.S. Quality ETF

(Free Report)

The GMO U.S. Quality ETF (QLTY) is an exchange-traded fund that mostly invests in total market equity. The fund is an actively managed fund that focuses on equities of high-quality US companies. The funds investments may include companies of any market capitalization. QLTY was launched on Nov 13, 2023 and is issued by GMO.

Recommended Stories

Want to see what other hedge funds are holding QLTY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for GMO U.S. Quality ETF (NYSEARCA:QLTYFree Report).

Institutional Ownership by Quarter for GMO U.S. Quality ETF (NYSEARCA:QLTY)

Receive News & Ratings for GMO U.S. Quality ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GMO U.S. Quality ETF and related companies with MarketBeat.com's FREE daily email newsletter.